ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Bolt Biotherapeutics Inc

Bolt Biotherapeutics Inc (BOLT)

0.5351
-0.0349
(-6.12%)
終了 1月2日 6:00AM
0.546
0.0109
(2.04%)
取引時間後: 9:59AM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
0.5351
買値
0.53
売値
0.5897
出来高
191,232
0.535 日の範囲 0.585
0.475 52 週間の範囲 1.56
時価総額
前日終値
0.57
始値
0.585
最終取引時間
財務取引量
US$ 104,745
VWAP
0.547738
平均取引量 (3 か月)
149,362
発行済株式数
38,273,002
配当利回り
-
PER
-0.30
1 株当たり利益 (EPS)
-1.81
歳入
7.88M
純利益
-69.2M

Bolt Biotherapeutics Inc について

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Dover, Delaware, USA
設立
-
Bolt Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker BOLT. The last closing price for Bolt Biotherapeutics was US$0.57. Over the last year, Bolt Biotherapeutics shares have traded in a share price range of US$ 0.475 to US$ 1.56.

Bolt Biotherapeutics currently has 38,273,002 shares in issue. The market capitalisation of Bolt Biotherapeutics is US$21.82 million. Bolt Biotherapeutics has a price to earnings ratio (PE ratio) of -0.30.

BOLT 最新ニュース

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Advanced to the highest dose level in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancersPresented updated preclinical activity of BDC-4182 and key learnings...

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from...

Bolt Biotherapeutics Announces Changes to its Board of Directors

REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of...

Bolt Biotherapeutics to Participate in Upcoming September Conferences

REDWOOD CITY, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.02514.921568627450.510.590.492477960.53915637CS
4-0.0909-14.52076677320.6260.650.4752081200.53925934CS
12-0.1349-20.13432835820.670.7180.4751493620.58819059CS
26-0.2016-27.36527758920.73670.780.4751595090.64404207CS
52-0.5949-52.64601769911.131.560.4751670540.82900528CS
156-4.3949-89.14604462474.935.160.4751877451.53706832CS
260-21.4549-97.566621191521.9943.070.4751902596.52076304CS

BOLT - Frequently Asked Questions (FAQ)

What is the current Bolt Biotherapeutics share price?
The current share price of Bolt Biotherapeutics is US$ 0.5351
How many Bolt Biotherapeutics shares are in issue?
Bolt Biotherapeutics has 38,273,002 shares in issue
What is the market cap of Bolt Biotherapeutics?
The market capitalisation of Bolt Biotherapeutics is USD 21.82M
What is the 1 year trading range for Bolt Biotherapeutics share price?
Bolt Biotherapeutics has traded in the range of US$ 0.475 to US$ 1.56 during the past year
What is the PE ratio of Bolt Biotherapeutics?
The price to earnings ratio of Bolt Biotherapeutics is -0.3
What is the cash to sales ratio of Bolt Biotherapeutics?
The cash to sales ratio of Bolt Biotherapeutics is 2.67
What is the reporting currency for Bolt Biotherapeutics?
Bolt Biotherapeutics reports financial results in USD
What is the latest annual turnover for Bolt Biotherapeutics?
The latest annual turnover of Bolt Biotherapeutics is USD 7.88M
What is the latest annual profit for Bolt Biotherapeutics?
The latest annual profit of Bolt Biotherapeutics is USD -69.2M
What is the registered address of Bolt Biotherapeutics?
The registered address for Bolt Biotherapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the Bolt Biotherapeutics website address?
The website address for Bolt Biotherapeutics is www.boltbio.com
Which industry sector does Bolt Biotherapeutics operate in?
Bolt Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BDMDBaird Medical Investment Holdings Ltd
US$ 7.6699
(630.47%)
89.74M
APMAptorum Group Ltd
US$ 2.799
(106.57%)
116.74M
COEPCoeptis Therapeutics Holdings Inc
US$ 5.44
(75.48%)
5.08M
VRMEVerifyMe Inc
US$ 1.332
(68.63%)
94.04M
VEEETwin Vee PowerCats Company
US$ 0.55
(53.59%)
5.62M
WATTEnergous Corporation
US$ 1.00
(-62.26%)
29.33M
SGMOSangamo Therapeutics Inc
US$ 1.02
(-56.41%)
44.56M
INTZIntrusion Inc
US$ 3.07
(-45.95%)
15.07M
KZIAKazia Therapeutics Ltd
US$ 1.78
(-42.58%)
708.99k
TOIIWOncology Institute Inc
US$ 0.0052
(-42.22%)
366.02k
SVMHSRIVARU Holding Ltd
US$ 0.0423
(26.65%)
794.74M
XTIAXTI Aerospace Inc
US$ 0.0422
(6.84%)
446.31M
EYENEyenovia Inc
US$ 0.1474
(30.10%)
412.83M
CRKNCrown Electrokinetics Corporation
US$ 0.146899
(5.91%)
402.05M
ONCOOnconetix Inc
US$ 0.6479
(48.26%)
270.47M

BOLT Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock